DaVita HealthCare (DVA) ended the recent trading session at $149.98, demonstrating a +1.19% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.25%.

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Investors in DaVita Inc (Symbol: DVA) saw new options begin trading today, for the March 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time ...

Dialysis provider DaVita Inc. (NYSE:DVA) reported Q2 CY2025 results beating Wall Street’s revenue expectations , with sales up 6.1% year on year to $3.38 billion. Its non-GAAP profit of $2.95 per ...

We came across a bullish thesis on DaVita Inc. on Roche Capital’s Substack by Pedro Ortiz. In this article, we will summarize ...

DaVita Inc. DVA delivered adjusted earnings per share (EPS) of $2.24 in the fourth quarter of 2024, up 19.8% year over year. The figure surpassed the Zacks Consensus Estimate by 1.4%. Find the latest ...

DaVita (NYSE:DVA) was a notable underperformer in the S&P 500 on Thursday as the dialysis services provider slightly missed Q4 revenue estimates and issued in-line guidance amid ongoing labor ...